MMRGlobal Shareholder Update on MMR Patent Litigation

MMRGlobal Shareholder Update on MMR Patent Litigation 
LOS ANGELES, CA -- (Marketwired) -- 01/23/14 --  MyMedicalRecords
Inc., a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF),
(collectively, "MMR"), today announced that based on court filings
dated January 21st 2014, MMR and Walgreen Co. are engaged in
continuing settlement discussions pertaining to a "potential
settlement or early resolution" to MMR's patent infringement
complaints pertaining to MMR's U.S. Patent No. 8,301,466 and U.S.
Patent No. 8,498,883 (the "883 Patent"). 
Walgreens and MMR filed a joint stipulation requesting an extension
of time for Walgreens to respond to MMR's complaint involving MMR's
'883 Patent, also referred to as United States District Court,
Central District of California Case No.: CV-13-9214-ODW (SHx). The
court filing states, amongst other things, that: 
"This Joint Stipulation Extending the Time to Respond to Plaintiff's
Complaint by Not More Than 30 Days is made and entered into by and
between Plaintiff MyMedicalRecords, Inc. ("MMR") and Defendant
Walgreen Co. ("Walgreens"), by and through their respective counsel,
with reference to the following facts: 
A. Whereas, on January 2, 2014, Plaintiff served its complaint on
Walgreens.
 B. Whereas, the parties are continuing discussions
regarding a potential settlement or early resolution of this matter. 
C. Whereas, the parties have agreed to extend Walgreens' time to
respond to the complaint by fourteen (14) days to February 6, 2014." 
Earlier this week, MMR announced that it is being awarded its 10th
U.S. patent from the United States Patent and Trademark Office, U.S.
Patent No. 8,645,161 entitled "Method and System for Providing Online
Records." MMRGlobal is a practicing entity and a leading provider of
Personal Health Records ("PHRs") and MMRPro document management and
imaging systems for health care professionals. This 10th and latest
patent includes 30 claims directed toward utilizing phones, wireless
and other web-enabled devices to allow for storing Personal Health
Records in the form of voice mail, faxes, email, HL7 and other media
pertaining to the receiving or sending of communications with health
care providers, pharmacies and other health care professionals.
Subject matter claimed also includes providing a user interface that
collects and displays prescriptions while helping submit them to
pharmacies. Additional claims allow users to annotate health records,
and set up appointment reminders with providers as well as medication
reminders through a built-in calendaring function, as well as the
collection and display of health insurance information. The 10th
patent adds to MMR's growing U.S. health IT patent portfolio which
also includes 18 pending U.S. applications in addition to issued U.S.
Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240;
8,352,287; 8,352,288; 8,498,883 and 8,626,532. The MMR patent
portfolio also includes numerous issued patents and pending
applications in other countries or regional authorities of commercial
interest including Australia, Singapore, New Zealand, Mexico, Japan,
Canada, China, Hong Kong, South Korea, Israel and Europe.  
Additional information can be found at:  
http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-irhome  
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. MMR's professional offering, MMRPro, is
designed to give physicians' offices an easy and cost-effective
solution to digitizing paper-based medical records and sharing them
with patients through an integrated patient portal. Through its
merger with Favrille, Inc. in January 2009, MMR acquired intellectual
property biotech assets that include anti-CD20 antibodies and data
and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials
for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more
about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video
tutorials of MMR's products and services at www.mmrtheater.com. 
Forward-Looking Statements 
  All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results
to be materially different from historical results or from any
results expressed or implied by such forward-looking statements. Some
can be identified by the use of words (and their derivations) such as
"need," "possibility," "potential," "intend," "offer," "development,"
"if," "negotiate," "when," "begun," "believe," "achieve," "will,"
"estimate," "expect," "maintain," "plan," and "continue," or the
negative of these words. Actual outcomes and results of operations
and the timing of selected events may differ materially from the
results predicted, and any reported results should not be considered
as an indication of future performance. Such statements are
necessarily based on assumptions and estimates and are subject to
various risks and uncertainties, including those relating to the
possible invalidity of the underlying assumptions and estimates and
possible changes or developments in economic, business, industry,
market, legal and regulatory circumstances and conditions and actions
taken or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such differences
include, but are not limited to: unexpected outcomes with respect to
intellectual property enforcement actions, claims of intellectual
property infringement and general intellectual property litigation;
our ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual
property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community and consumer retail market; business prospects,
results of operations or financial condition; risks related to the
current uncertainty and instability in financial and lending markets,
including global economic uncertainties; the timing and volume of
sales and installations; the length of sales cycles and the
installation process; the market's acceptance of new product and
service introductions; competitive product offerings and promotions;
changes in government laws and regulations including the 2009 HITECH
Act and changes in Meaningful Use and the 2010 Affordable Care Act;
future changes in tax legislation and initiatives in the healthcare
industry; undetected errors in our products; the possibility of
interruption at our data centers; risks related to third party
vendors; risks related to obtaining and integrating third-party
licensed technology; risks related to a security breach by third
parties; risks associated with recruitment and retention of key
personnel; other litigation matters; uncertainties associated with
doing business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of the date
of this release and, except as required by applicable law, does not
undertake any obligation to update any forward-looking statements
contained in this release as a result of new information, future
events or otherwise.  
CONTACT: 
Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033 
 
 
Press spacebar to pause and continue. Press esc to stop.